See also this year's filing and all EDGAR filings for this company.
PDF Report 0000931059_2023_Rennova_Health_Inc.pdf
Logs
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Liabilities', 'missing_ratio': 4.679831657095631e-08, 'aggregate_val': 21368289, 'exp_sum': 21368290, 'exp_to_value': {'LongTermLiabilities': 0, 'LiabilitiesCurrent': 19564768, 'remainder_Liabilities': 1803522}} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0000931059, Rennova Health Inc
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 259,443 |
| 1 | AssetsNonCurrent | 574,256 |
| 2 | AssetsCurrent | 6,363,162 |
| 3 | PropertyPlantAndEquipment | 4,194,299 |
| 4 | remainder_Assets | 9,181,602 |
| 5 | LongTermLiabilities | 359,193 |
| 6 | LiabilitiesCurrent | 49,308,157 |
| 7 | remainder_Liabilities | 0 |
| 8 | LaborExpense | 0 |
| 9 | CostOfGoodsAndServicesSold | 6,767,921 |
| 10 | GeneralAndAdministrativeExpense | 7,208,414 |
| 11 | GoodwillImpairmentLoss | 0 |
| 12 | OperatingCostsAndExpenses | 0 |
| 13 | DepreciationDepletionAndAmortization | 469,371 |
| 14 | SellingAndMarketingExpense | 0 |
| 15 | ResearchAndDevelopmentExpense | 0 |
| 16 | remainder_Expenses | 312,849 |
| 17 | remainder_Revenues | 13,036,172 |
| 18 | remainder_NetIncome | -1,570,672 |
| 19 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 20,572,762 |
| 1 | Liabilities | 49,667,350 |
| 2 | Expenses | 14,758,555 |
| 3 | Revenues | 13,036,172 |
| 4 | StockholdersEquity | -29,094,588 |
| 5 | NetIncome | -3,293,055 |
| 6 | ComprehensiveNetIncome | -3,293,055 |
| 7 | BaseVar | 49,802,756 |
| 8 | EconomicCapitalRatio | -2.40 |
Edgar->Model Mapping
Feature Distribution
Change over Time
